Literature DB >> 24381141

Vitamin D receptor gene polymorphisms and esophageal cancer risk in a Chinese population: a negative study.

Haiyong Gu1, Xu Wang, Liang Zheng, Weifeng Tang, Changqing Dong, Liming Wang, Yijun Shi, Aizhong Shao, Guowen Ding, Chao Liu, Ruiping Liu, Suocheng Chen, Jun Yin.   

Abstract

Vitamin D receptor (VDR) gene polymorphisms have been reported to influence susceptibility to some malignant cancers. However, there were few published findings on the association between VDR polymorphisms and esophageal cancer susceptibility. Our investigation was aimed to obtain a precise estimation of the association between VDR polymorphisms and esophageal cancer susceptibility. We conducted a hospital-based case-control study to evaluate the genetic effects of functional single-nucleotide polymorphisms VDR rs2107301 T>C, rs2228570 C>T, rs1989969 C>T and rs11568820 G>A on the development of esophageal cancer. A total of 629 esophageal squamous cell carcinoma (ESCC) cases and 686 controls were enrolled for this study. The genotypes were determined using ligation detection reaction method. There were no significant associations between the four VDR variants and ESCC risk. Stratified analyses indicated a significantly increased risk of ESCC associated with VDR rs2107301 T>C polymorphism among patients who were drinking. These findings demonstrated that the risk of ESCC associated with VDR rs2107301 T>C polymorphism may be modified by lifestyle factors such as drinking. However, the results should be validated in larger well-designed studies in future.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24381141     DOI: 10.1007/s12032-013-0827-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

Review 1.  Molecular nature of the vitamin D receptor and its role in regulation of gene expression.

Authors:  P W Jurutka; G K Whitfield; J C Hsieh; P D Thompson; C A Haussler; M R Haussler
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  Newly identified actions of the vitamin D endocrine system.

Authors:  M R Walters
Journal:  Endocr Rev       Date:  1992-11       Impact factor: 19.871

3.  1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages.

Authors:  Yunzi Chen; Weicheng Liu; Tao Sun; Yong Huang; Youli Wang; Dilip K Deb; Dosuk Yoon; Juan Kong; Ravi Thadhani; Yan Chun Li
Journal:  J Immunol       Date:  2013-02-22       Impact factor: 5.422

4.  Vitamin d receptor gene variants and esophageal adenocarcinoma risk: a population-based case-control study.

Authors:  C K Chang; H G Mulholland; M M Cantwell; L A Anderson; B T Johnston; A J McKnight; P D Thompson; R G P Watson; L J Murray
Journal:  J Gastrointest Cancer       Date:  2012-09

5.  Cloning and expression of full-length cDNA encoding human vitamin D receptor.

Authors:  A R Baker; D P McDonnell; M Hughes; T M Crisp; D J Mangelsdorf; M R Haussler; J W Pike; J Shine; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

6.  Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group.

Authors:  A C Lundin; P Söderkvist; B Eriksson; M Bergman-Jungeström; S Wingren
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

7.  Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line.

Authors:  M G Thomas; S Tebbutt; R C Williamson
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

8.  Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia.

Authors:  Christian C Abnet; Wen Chen; Sanford M Dawsey; Wen-Qiang Wei; Mark J Roth; Bing Liu; Ning Lu; Philip R Taylor; You-Lin Qiao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09       Impact factor: 4.254

9.  Vitamin D receptor gene polymorphism is associated with metastatic breast cancer.

Authors:  M Ruggiero; S Pacini; S Aterini; C Fallai; C Ruggiero; P Pacini
Journal:  Oncol Res       Date:  1998       Impact factor: 5.574

10.  Vitamin D receptor variants and the malignant melanoma risk: a population-based study.

Authors:  P Gapska; R J Scott; P Serrano-Fernandez; A Mirecka; I Rassoud; B Górski; C Cybulski; T Huzarski; T Byrski; L Nagay; R Maleszka; M Sulikowski; J Lubinski; T Debniak
Journal:  Cancer Epidemiol       Date:  2009-07-18       Impact factor: 2.984

View more
  6 in total

1.  Development of novel parameter for monitoring of malignant melanoma progression.

Authors:  Ivana Špaková; Miroslava Rabajdová; Katarína Dubayová; Vladimíra Nagyová; Martina Bago Pilátová; Mária Mareková
Journal:  Pract Lab Med       Date:  2020-10-21

2.  Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population.

Authors:  Qiliu Peng; Shi Yang; Xianjun Lao; Ruolin Li; Zhiping Chen; Jian Wang; Xue Qin; Shan Li
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

3.  Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.

Authors:  Davide Serrano; Patrizia Gnagnarella; Sara Raimondi; Sara Gandini
Journal:  Eur J Cancer Prev       Date:  2016-01       Impact factor: 2.497

4.  Polymorphisms of VDR gene and risk of gastric cardiac adenocarcinoma in Chinese population.

Authors:  Jun Yin; Huiwen Pan; Tao Long; Lu Lv; Peng Zhai; Chao Liu; Aizhong Shao; Yijun Shi; Yangyong Sun; Jingfeng Zhu; Liming Wang; Guowen Ding; Suocheng Chen; Weifeng Tang; Cheng Qian; Lijie Tan; Haiyong Gu
Journal:  Oncotarget       Date:  2017-07-11

5.  Vitamin D Receptor Is a Sepsis-Susceptibility Gene in Chinese Children.

Authors:  Danni He; Xiuxiu Lu; Wei Li; Yuanyuan Wang; Ning Li; Yuanmei Chen; Lipeng Zhang; Wenquan Niu; Qi Zhang
Journal:  Med Sci Monit       Date:  2021-10-24

6.  Association of Vitamin D Receptor Cdx-2 Polymorphism With Cancer Risk: A Meta-Analysis.

Authors:  Zhi-Ming Dai; Yu-Lang Fei; Wang-Gang Zhang; Jie Liu; Xing-Mei Cao; Qiu-Min Qu; Yan-Chun Li; Shuai Lin; Meng Wang; Zhi-Jun Dai
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.